Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Comparative evaluation of three culture methods for the isolation of mycobacteria from clinical samples.

Sorlozano A, Soria I, Roman J, Huertas P, Soto MJ, Piedrola G, Gutierrez J.

J Microbiol Biotechnol. 2009 Oct;19(10):1259-64.

2.

Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT/ALERT MB automated culture systems.

Parrish N, Dionne K, Sweeney A, Hedgepeth A, Carroll K.

Diagn Microbiol Infect Dis. 2009 Mar;63(3):342-5. doi: 10.1016/j.diagmicrobio.2008.11.008. Epub 2009 Jan 24.

PMID:
19168305
3.

Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):7-10.

4.
5.

An official ATS statement: hepatotoxicity of antituberculosis therapy.

Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR; ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee.

Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52. Review.

PMID:
17021358
6.

Adverse reactions to first-line antituberculosis drugs.

Forget EJ, Menzies D.

Expert Opin Drug Saf. 2006 Mar;5(2):231-49. Review.

PMID:
16503745
7.

Side effects of antituberculosis therapy.

Resi D, Gagliotti C, Moro ML.

Am J Respir Crit Care Med. 2004 Feb 15;169(4):542; author reply 542. No abstract available.

PMID:
14766664
8.

Treatment of tuberculosis.

American Thoracic Society; CDC; Infectious Diseases Society of America.

MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77. No abstract available. Erratum in: MMWR Recomm Rep. 2005 Jan 7;53(51):1203. Dosage error in article text.

9.

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.

Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D.

Am J Respir Crit Care Med. 2003 Jun 1;167(11):1472-7. Epub 2003 Jan 31.

PMID:
12569078
10.

Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens.

Scarparo C, Piccoli P, Rigon A, Ruggiero G, Ricordi P, Piersimoni C.

Diagn Microbiol Infect Dis. 2002 Oct;44(2):157-61.

PMID:
12458122
11.

Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Löwenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicenter study.

Piersimoni C, Scarparo C, Callegaro A, Tosi CP, Nista D, Bornigia S, Scagnelli M, Rigon A, Ruggiero G, Goglio A.

J Clin Microbiol. 2001 Feb;39(2):651-7.

12.

Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria.

Williams-Bouyer N, Yorke R, Lee HI, Woods GL.

J Clin Microbiol. 2000 Nov;38(11):4167-70.

13.

Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis.

Whyte T, Hanahoe B, Collins T, Corbett-Feeney G, Cormican M.

J Clin Microbiol. 2000 Aug;38(8):3131-2. No abstract available.

14.

Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens.

Chien HP, Yu MC, Wu MH, Lin TP, Luh KT.

Int J Tuberc Lung Dis. 2000 Sep;4(9):866-70.

PMID:
10985656
15.

Comparison of the MB/BacT and BACTEC MGIT 960 system for recovery of mycobacteria from clinical specimens.

Yan JJ, Huang AH, Tsai SH, Ko WC, Jin YT, Wu JJ.

Diagn Microbiol Infect Dis. 2000 May;37(1):25-30.

PMID:
10794936
18.

Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.

Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D.

J Clin Microbiol. 1999 Nov;37(11):3578-82.

19.
20.

Supplemental Content

Support Center